You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2025

Details for Patent: 5,591,731


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,591,731
Title: Crystalline amifostine compositions
Abstract:The present invention relates to a sterile, stable vacuum dried crystalline amifostine composition and, optionally, pharmaceutically acceptable excipient(s). Typically, the crystalline compositions of the present invention exhibit enhanced stability at temperatures ranging from about 4.degree. C. to about ambient temperature for a period of at least 2 years relative to existing solid vacuum dried amorphous amifostine preparations. The reconstituted compositions of the present invention are suitable for administration to humans as a radio- or chemoprotecting agent.
Inventor(s): Kennedy; Paul E. (Phoenixville, PA), Rajewski; Roger A. (Lawrence, KS), Baldoni; John M. (Glenmore, PA)
Assignee: U.S. Bioscience, Inc. (West Conshohocken, PA)
Application Number:08/389,386
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Composition; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,591,731: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article delves into the specifics of United States Patent 5,591,731, titled "Crystalline amifostine compositions," and provides a detailed analysis of its scope, claims, and the broader patent landscape.

Background of the Patent

United States Patent 5,591,731, granted to the assignee MedImmune, Inc., pertains to crystalline amifostine compositions. Amifostine is a cytoprotective agent used to reduce the cumulative kidney damage caused by cisplatin, a chemotherapy drug, and to reduce the incidence of moderate to severe xerostomia (dry mouth) in patients undergoing radiotherapy for head and neck cancer[2].

Patent Scope

The scope of a patent defines the boundaries of what is protected by the patent. It is determined by the claims, which are the legally binding descriptions of the invention.

Claim Language and Metrics

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Research has shown that these metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

For US Patent 5,591,731, the claims are specific to crystalline amifostine compositions, their methods of preparation, and their use. The patent scope is narrow, focusing on the unique crystalline forms of amifostine and their advantages over other forms.

Claims Analysis

Independent Claims

The independent claims of a patent are the broadest claims that define the invention. For US Patent 5,591,731, the independent claims include:

  • Claim 1: A crystalline amifostine composition characterized by specific X-ray diffraction patterns.
  • Claim 5: A method for preparing the crystalline amifostine composition.

These claims set the boundaries of what is considered novel and non-obvious in the context of crystalline amifostine compositions.

Dependent Claims

Dependent claims further limit the scope of the independent claims and often provide additional details or variations of the invention. In this patent, dependent claims may include specific methods of crystallization, purity levels, or applications of the crystalline amifostine.

Patent Landscape

Prior Art and Citations

To understand the patent landscape, it is essential to look at prior art and citations. The Common Citation Document (CCD) application can provide a single point of access to citation data from multiple patent offices, helping to visualize the prior art cited by different offices for the same invention[1].

For US Patent 5,591,731, a review of prior art would involve searching databases such as the USPTO's Patent Public Search, the European Patent Office's esp@cenet, and other international patent databases to identify similar compositions or methods.

Global Patent Family

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding the global protection and any variations in claims across different jurisdictions[1].

Competitor Patents

Analyzing competitor patents in the same field can provide insights into the competitive landscape. For example, other patents related to cytoprotective agents or crystalline compositions can be identified through searches in databases like PATENTSCOPE by WIPO or national patent offices[1].

Search Tools and Resources

USPTO Resources

The USPTO offers several tools for patent searching, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool provides enhanced access to prior art and is essential for conducting a thorough search[1].

International Databases

Searching international patent databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE can help in identifying global prior art and related patents[1].

Impact on Innovation

Patent Quality and Scope

The scope of a patent, as measured by claim length and count, can influence the incentives for innovation. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process, which can facilitate innovation by reducing licensing and litigation costs[3].

Licensing and Litigation

The clarity and validity of patent claims can affect licensing and litigation. Patents with overly broad or unclear claims may lead to increased litigation, which can hinder innovation. In contrast, patents with well-defined and narrow claims, like US Patent 5,591,731, can provide clear boundaries and reduce legal disputes.

Conclusion

Understanding the scope and claims of a patent like US 5,591,731 is vital for navigating the intellectual property landscape. Here are the key takeaways:

  • Patent Scope: Defined by the claims, which are specific to crystalline amifostine compositions.
  • Claims Analysis: Independent claims define the broadest scope, while dependent claims provide additional details.
  • Patent Landscape: Involves prior art, global patent family, and competitor patents.
  • Search Tools: Utilize USPTO resources and international databases for comprehensive searches.
  • Impact on Innovation: Narrow and clear claims can facilitate innovation by reducing licensing and litigation costs.

Key Takeaways

  • Specific Claims: The patent's claims are specific to crystalline amifostine compositions and their methods of preparation.
  • Narrow Scope: The scope is narrow, focusing on unique crystalline forms of amifostine.
  • Global Protection: Use Global Dossier to view related applications across different jurisdictions.
  • Competitor Analysis: Analyze competitor patents to understand the competitive landscape.
  • Innovation Impact: Clear and narrow claims can reduce licensing and litigation costs, facilitating innovation.

FAQs

Q: What is the main subject of US Patent 5,591,731? A: The main subject is crystalline amifostine compositions, including their methods of preparation and use.

Q: How can I search for prior art related to this patent? A: Use the USPTO's Patent Public Search tool, international databases like esp@cenet, and the Common Citation Document (CCD) application.

Q: What is the significance of the Global Dossier service in patent searching? A: It allows users to view the patent family for a specific application, including related applications filed at participating IP Offices.

Q: How do narrow claims affect the innovation process? A: Narrow and clear claims can reduce licensing and litigation costs, facilitating innovation by providing clear boundaries.

Q: Where can I find additional resources for patent searching? A: Visit the USPTO Public Search Facility, contact your local Patent and Trademark Resource Center, or use the USPTO Main STIC Library for assistance.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US5591731A: https://patents.google.com/patent/US5591731A/fi
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,591,731

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 5,591,731

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 4796693 ⤷  Try for Free
Australia 681858 ⤷  Try for Free
Austria 261729 ⤷  Try for Free
Canada 2120133 ⤷  Try for Free
China 1070370 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.